Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

While many consumers have hopped on the Ozempic bandwagon in recent months to help them lose weight, few studies have looked ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being ...

Could the now popular weight-loss injection drugs be a solution for ... In this respect, the use of liraglutide in children with an extreme form of obesity could be a significant supplementary ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...